Market Overview:
The global drugs for traveler's diarrhea market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of traveler's diarrhea, rising awareness about preventive measures, and technological advancements in drug delivery systems. The global drugs for traveler's diarrhea market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into anti-motility agents, bismuth subsalicylate (Pepto-Bismol), and antibiotics. Anti-motility agents are further subsegmented into loperamide hydrochloride and diphenoxylate with atropine sulfate. Bismuth subsalicylate (Pepto-Bismol) is used as an over-the-counter medication for treating mild cases of traveler's diarrhea caused by bacteria or parasites such as E coli O157:H7, Salmonella typhi, Giardia lamblia,. It also helps relieve symptoms such as nausea,, vomiting,, and abdominal cramps. Antibiotics are used to treat more severe cases of traveler's diarrhea caused by bacteria or parasites such as Campylobacter jejuni,, Shigella sonnei,, Vibrio cholerae,. On the basis of application,.
Product Definition:
Drugs for Traveler's Diarrhea are medications that can help to treat and prevent traveler's diarrhea. They work by killing the bacteria that can cause the diarrhea, and by helping to restore the balance of bacteria in the intestine. Drugs for Traveler's Diarrhea are important because they can help to reduce symptoms and prevent dehydration.
Anti-motility agents:
Anti-motility agents are drugs that prevent the movement of bacteria in a specific direction. They can be used to treat diarrhea caused by certain foods and also help reduce the number of bowel movements per day. Anti-motility agents are not intended to replace proper food consumption or hydration; they merely act as an aid to enable normal functioning when consumed along with adequate food and fluid intake.
Bismuth Subsalicylate (Pepto-Bismol):
Bismuth subsalicylate is an oral drug used to treat diarrhea. It works by reducing the number of loose stools and may also have a mild laxative effect. Bismuth subsalicylate has been approved by the U.S Food and Drug Administration (FDA) for treatment of acute diarrhea in adults as well as children over the age of three years, which is attributed to its excellent safety profile.
Application Insights:
The adult segment held the largest share of over 70.0% in 2017. The application of anti-motility agents is one of the major reasons for traveler¢â‚¬â„¢s diarrhea and it is therefore expected to be the fastest growing segment during forecast years owing to rising travel activities across various regions including Europe, North America and Asia Pacific.
In addition, a rise in number of tourists visiting developing countries such as India China etc due to increasing disposable income levels has increased the risk factor for development of traveler¢â‚¬™s diarrhea among Indian population particularly during monsoon season from July to September every year. This factor is expected to drive demand from Asia Pacific region over next few years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness about drug treatment, presence of key manufacturers and favorable reimbursement policies for travelers diarrhea treatment in U.S & Canada.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising incidence of traveler's diarrhea coupled with increasing number of tourists traveling across various countries in Asia Pacific including India, China, Japan and Australia among others are contributing towards growth significantly. In addition, growing medical tourism industry due to availability of advanced treatments at cheaper costs will also boost regional market growth over the next eight years to come (2030).
Growth Factors:
- Increasing prevalence of traveler's diarrhea due to changing lifestyles and global travel
- Growing awareness about the availability and benefits of drugs for traveler's diarrhea
- Rising demand for convenient, easy-to-use drug therapies for traveler's diarrhea
- Increasing number of product launches and approvals by regulatory agencies
- Growing investments in research and development by pharmaceutical companies to develop novel drugs for traveler's diarrhea
Scope Of The Report
Report Attributes
Report Details
Report Title
Drugs for Traveler's Diarrhea Market Research Report
By Type
Anti-motility agents, Bismuth Subsalicylate (Pepto-Bismol), Antibiotics
By Application
Adult, Children
By Companies
GSK, Salix Pharmaceuticals, Chiesi Farmaceutici, Cosmo Pharmaceuticals, Nippon Shinyaku, Prokarium Limited, Scandinavian Biopharma, Sigmoid Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Drugs for Traveler's Diarrhea Market Report Segments:
The global Drugs for Traveler's Diarrhea market is segmented on the basis of:
Types
Anti-motility agents, Bismuth Subsalicylate (Pepto-Bismol), Antibiotics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Salix Pharmaceuticals
- Chiesi Farmaceutici
- Cosmo Pharmaceuticals
- Nippon Shinyaku
- Prokarium Limited
- Scandinavian Biopharma
- Sigmoid Pharma
Highlights of The Drugs for Traveler's Diarrhea Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-motility agents
- Bismuth Subsalicylate (Pepto-Bismol)
- Antibiotics
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drugs for Traveler's Diarrhea Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drugs for traveler's diarrhea are medications that can be taken to treat the symptoms of the condition, such as diarrhea. These medications may include antibiotics, antidiarrheals, and stool softeners.
Some of the major companies in the drugs for traveler's diarrhea market are GSK, Salix Pharmaceuticals, Chiesi Farmaceutici, Cosmo Pharmaceuticals, Nippon Shinyaku, Prokarium Limited, Scandinavian Biopharma, Sigmoid Pharma.
The drugs for traveler's diarrhea market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drugs for Traveler's Diarrhea Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drugs for Traveler's Diarrhea Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drugs for Traveler's Diarrhea Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drugs for Traveler's Diarrhea Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drugs for Traveler's Diarrhea Market Size & Forecast, 2018-2028
4.5.1 Drugs for Traveler's Diarrhea Market Size and Y-o-Y Growth
4.5.2 Drugs for Traveler's Diarrhea Market Absolute $ Opportunity
Chapter 5 Global Drugs for Traveler's Diarrhea Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drugs for Traveler's Diarrhea Market Size Forecast by Type
5.2.1 Anti-motility agents
5.2.2 Bismuth Subsalicylate (Pepto-Bismol)
5.2.3 Antibiotics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drugs for Traveler's Diarrhea Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drugs for Traveler's Diarrhea Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drugs for Traveler's Diarrhea Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drugs for Traveler's Diarrhea Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drugs for Traveler's Diarrhea Analysis and Forecast
9.1 Introduction
9.2 North America Drugs for Traveler's Diarrhea Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drugs for Traveler's Diarrhea Market Size Forecast by Type
9.6.1 Anti-motility agents
9.6.2 Bismuth Subsalicylate (Pepto-Bismol)
9.6.3 Antibiotics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drugs for Traveler's Diarrhea Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drugs for Traveler's Diarrhea Analysis and Forecast
10.1 Introduction
10.2 Europe Drugs for Traveler's Diarrhea Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drugs for Traveler's Diarrhea Market Size Forecast by Type
10.6.1 Anti-motility agents
10.6.2 Bismuth Subsalicylate (Pepto-Bismol)
10.6.3 Antibiotics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drugs for Traveler's Diarrhea Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drugs for Traveler's Diarrhea Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drugs for Traveler's Diarrhea Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drugs for Traveler's Diarrhea Market Size Forecast by Type
11.6.1 Anti-motility agents
11.6.2 Bismuth Subsalicylate (Pepto-Bismol)
11.6.3 Antibiotics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drugs for Traveler's Diarrhea Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drugs for Traveler's Diarrhea Analysis and Forecast
12.1 Introduction
12.2 Latin America Drugs for Traveler's Diarrhea Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drugs for Traveler's Diarrhea Market Size Forecast by Type
12.6.1 Anti-motility agents
12.6.2 Bismuth Subsalicylate (Pepto-Bismol)
12.6.3 Antibiotics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drugs for Traveler's Diarrhea Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drugs for Traveler's Diarrhea Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drugs for Traveler's Diarrhea Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drugs for Traveler's Diarrhea Market Size Forecast by Type
13.6.1 Anti-motility agents
13.6.2 Bismuth Subsalicylate (Pepto-Bismol)
13.6.3 Antibiotics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drugs for Traveler's Diarrhea Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drugs for Traveler's Diarrhea Market: Competitive Dashboard
14.2 Global Drugs for Traveler's Diarrhea Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 Salix Pharmaceuticals
14.3.3 Chiesi Farmaceutici
14.3.4 Cosmo Pharmaceuticals
14.3.5 Nippon Shinyaku
14.3.6 Prokarium Limited
14.3.7 Scandinavian Biopharma
14.3.8 Sigmoid Pharma
